FinnCap restated their corporate rating on shares of Evgen Pharma (LON:EVG) in a report issued on Thursday morning, ThisIsMoney.Co.Uk reports. They currently have a GBX 35 ($0.46) price objective on the stock, down from their previous price objective of GBX 45 ($0.59).
Shares of EVG stock opened at GBX 19.75 ($0.26) on Thursday. The firm has a market capitalization of $19.55 million and a price-to-earnings ratio of -6.58. Evgen Pharma has a 52 week low of GBX 12.70 ($0.17) and a 52 week high of GBX 33 ($0.43).
About Evgen Pharma
See Also: Systematic Risk and Investors
Receive News & Ratings for Evgen Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evgen Pharma and related companies with MarketBeat.com's FREE daily email newsletter.